INOVIO releases positive results from Phase 1 trial of Covid-19 vaccine
INO-4800 is a DNA vaccine candidate being developed to protect against the novel coronavirus SARS-CoV-2, which causes Covid-19
GSK’s Duvroq approved in Japan for anaemia related to chronic kidney disease
30 Jun 20Duvroq has been designed to provide an orally-convenient treatment option, avoid administration challenges and need for cold storage…
Roche gets FDA approval for Phesgo to treat HER2-positive breast cancer
30 Jun 20Phesgo offers faster administration of Perjeta and Herceptin under the skin in just minutes, compared to hours with…
Carlyle Group to acquire 20% stake in Piramal Pharma for $490m
29 Jun 20Piramal Pharma includes Piramal Pharma Solutions, an end-to-end contract development and manufacturing (CDMO) business, Piramal Critical Care, a…
Bristol Myers Squibb secures EC approval for Reblozyl to treat anaemia
29 Jun 20Reblozyl is an erythroid maturation agent that regulates late-stage red blood cell (RBC) maturation to reduce or prevent…
Novartis reaches $347m settlement with DOJ and SEC over FCPA investigations
26 Jun 20Novartis, along with certain of its subsidiaries, has agreed to pay $233.9m to the DOJ and $112.8m to…
Hansa Biopharma granted positive CHMP opinion for Idefirix for kidney transplant
26 Jun 20The European Medicines Agency has accepted the company’s application for review of the marketing authorisation of imlifidase in…
Sosei, AbbVie collaborate on new medicine for autoimmune diseases
25 Jun 20The collaboration will leverage advanced StaR technology and SBDD platform to discover the advanced medicines that modulate GPCRs
Merck gets FDA nod for KEYTRUDA to treat squamous cell carcinoma
25 Jun 20KEYTRUDA is an anti PD-1 therapy that works by enhancing the body’s immune system to detect and fight…
Gilead to acquire 49.9% stake in Pionyr Immunotherapeutics for $275m
24 Jun 20Pionyr Immunotherapeutics is a privately held pharmaceutical company engaged in developing a research approach, dubbed Myeloid Tuning